Therefore, whether to target TRPM8 with either an agonist or antagonist may depend on which symptom is most troublesome to the patient; individuals with a primary complaint of mechanical hyperalgesia may respond best to TRPM8 agonists, while those with cold hyperalgesia may respond best to TRPM8 antagonists. The gene discussed is TRPM8; the disease is chronic obstructive pulmonary disease.